Related Experiment Video
Updated: Apr 7, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Giant Esophageal GIST: Diagnostic and Therapeutic Challenge - Case Report
Abstract:
GIST are rare mesenchymal tumors of the digestive tract (less than 1% of the digestive tract neoplasia). Of these, less than 1% are found in the esophagus. Surgery is the main treatment of GIST and is supported by targeted therapy with tyrosine kinase inhibitors like imatinibmesylate. We present the case of a female patient of 51 years, admitted in our clinic for a bulky tumor in the posterior mediastinum, diagnosed after investigations performed for fatigue for the great efforts. Clinical examination was unspecific. Chest X-ray and thoraco-abdominal CT identified a widening of the mediastinum through a posterior mediastinal tumor mass, determining a deviation to the left of the thoracic esophagus without causing not abledysphagia or respiratory symptoms. It was decided surgery by thoracotomy in V right intercostal space and total excision of the tumor was performed. Histopathology examination confirmed the preoperative suspicion of esophageal GIST. Prognosis is reserved, the risk of relapse is very high given the fact that the tumor was extracted fragmented. Currently the patient is under treatment with imatinib mesylate and entered into clinical and imaging follow-up program, according to clinical guidelines.
Insights
This case study details a rare esophageal gastrointestinal stromal tumor (GIST) successfully removed surgically. The patient is now undergoing targeted therapy with imatinib mesylate due to a high risk of relapse.
Area of Science:
- Gastroenterology
- Oncology
- Thoracic Surgery
Background:
- Gastrointestinal stromal tumors (GIST) are rare mesenchymal neoplasms, accounting for less than 1% of digestive tract tumors.
- Esophageal GIST represent a very small subset of these rare tumors, posing unique diagnostic and therapeutic challenges.
Observation:
- A 51-year-old female presented with fatigue, leading to the discovery of a bulky posterior mediastinal mass.
- Imaging revealed a mediastinal tumor deviating the thoracic esophagus without causing dysphagia or respiratory compromise.
Findings:
- Surgical exploration via thoracotomy confirmed and completely excised the esophageal GIST.
- Histopathology confirmed the diagnosis, but fragmented tumor removal indicated a high risk of recurrence.
Implications:
- Complete surgical resection is the primary treatment for esophageal GIST.
- Adjuvant therapy with tyrosine kinase inhibitors, such as imatinib mesylate, is crucial for managing high-risk cases and preventing relapse.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
